Aim
The study aimed to evaluate medication use in children from birth to 12 years in the private healthcare sector, in terms of active ingredients, dosage forms and appropriateness.
Methods
A retrospective drug utilisation study was conducted using 2024 data of a South African private healthcare sector medical insurance administrator database. The database contained approximately 4.2 million records for medicine, medical devices and procedures dispensed by hospitals, medical practitioners and pharmacies, of which 718 707 were for children 12 years and younger. The Anatomical Therapeutic Chemical (ATC) Classification system was used to extract all medicines dispensed. Ethical approval for the study was obtained from the Nelson Mandela University’s research ethics committee.
Results
Medicine records of 16 541 patients were analysed (average age 6.39 (SD=3.61) years, 50.83% males). A total of 254 742 medicines were dispensed (54.40% to males). Most medicines were Schedule 2 and Schedule 4. A third (33.17%) of products were respiratory system medicines, followed by general anti-infectives for systemic use (14.89%, n=37 937) and central nervous system products (14.81%). Paracetamol (ATC code N02BE01) was overall the most often dispensed active ingredient, followed by pseudoephedrine and combinations (mostly syrups) (R01BA52) and chlorphenamine syrups (R06AB04). Amoxicillin, and the combination of amoxicillin and a beta-lactamase inhibitor, were the most often dispensed anti-infectives, followed by cephalosporins. Anti-infective dispensing peaked in May 2024 (13.34% of all anti-infective prescriptions), followed by a smaller peak in August 2024.
Conclusion
The study emphasised the importance of including diagnostic codes, and the necessity to monitor anti-infective prescribing.
Keywords: Anti-infectives, Database; Children; Drug utilisation; Respiratory system





